Respiratory
2 drugs are in development for Acute Respiratory Distress Syndrome (ARDS).
- Companies
- 2
- Clinical trials
- 9
BioSniper AIPage evidence connected
Prepared research question
Which programs lead the Acute Respiratory Distress Syndrome (ARDS) pipeline—and what evidence could change the picture?
Run cited research
Traceable citations · Unknowns marked
Drug Pipeline by Phase
Phase 3(1)
| Drug | Company |
|---|---|
| eb05 | Edesa Biotech, Inc. (EDSA) |
Preclinical(1)
| Drug | Company |
|---|---|
| php-303 | Peak Bio, Inc. (PKBO) |
About this indication
Acute Respiratory Distress Syndrome (ARDS) context
Respiratory·MeSH: Respiratory Distress Syndrome (D012128)
Narrower concept of MeSH descriptor Respiratory Distress Syndrome
Frequently asked questions
How many drugs are in development for Acute Respiratory Distress Syndrome (ARDS)?
BioSniper tracks 2 drugs in development for Acute Respiratory Distress Syndrome (ARDS) across 2 companies.
How many clinical trials target Acute Respiratory Distress Syndrome (ARDS)?
There are 9 clinical trials targeting Acute Respiratory Distress Syndrome (ARDS) tracked by BioSniper.